Clinical characteristics and risk factors for SARS-CoV-2 infection in pregnant women attending a third level reference center in Mexico City

J Matern Fetal Neonatal Med. 2022 Dec;35(25):5927-5931. doi: 10.1080/14767058.2021.1902500. Epub 2021 Mar 26.

Abstract

Background: COVID-19 symptoms vary widely among pregnant women. We aimed to assess the most frequent symptoms amongst pregnant women with SARS-CoV-2 infection in a tertiary hospital in Mexico City.

Methods: A cross-sectional study of pregnant women attending the National Institute of Perinatology in Mexico City was performed. All women who attended the hospital, despite their symptoms, were tested for SARS-CoV-2. A multivariate-age-adjusted logistic regression was used to assess the association between the main outcome and each characteristic of the clinical history.

Results: A total of 1880 women were included in the data analysis. Among all women, 30.74% (n = 578) had a positive PCR for SARS-CoV-2 from which 2.7 (n = 50) were symptomatic. Symptoms associated with a positive PCR result were headache (p=.01), dyspnea (p=.043), and myalgia (p=.043).

Conclusions: At universal screening for SARS-CoV-2, one-third of the population had a positive result, while those symptoms associated with a positive PCR were headache, dyspnea, and myalgia.

Keywords: COVID-19; SARS-CoV-2; coronavirus 2019; pregnancy; universal screening.

MeSH terms

  • COVID-19* / epidemiology
  • Cross-Sectional Studies
  • Dyspnea
  • Female
  • Headache
  • Humans
  • Mexico / epidemiology
  • Myalgia
  • Pregnancy
  • Pregnancy Complications, Infectious* / diagnosis
  • Pregnancy Complications, Infectious* / epidemiology
  • Pregnant Women
  • Risk Factors
  • SARS-CoV-2